165 related articles for article (PubMed ID: 11082150)
1. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension.
Rumantir MS; Kaye DM; Jennings GL; Vaz M; Hastings JA; Esler MD
Hypertension; 2000 Nov; 36(5):824-9. PubMed ID: 11082150
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
Schlaich MP; Lambert E; Kaye DM; Krozowski Z; Campbell DJ; Lambert G; Hastings J; Aggarwal A; Esler MD
Hypertension; 2004 Feb; 43(2):169-75. PubMed ID: 14610101
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
[TBL] [Abstract][Full Text] [Related]
4. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
[TBL] [Abstract][Full Text] [Related]
5. Neural mechanisms in human obesity-related hypertension.
Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients.
Esler M; Jackman G; Bobik A; Leonard P; Kelleher D; Skews H; Jennings G; Korner P
Hypertension; 1981; 3(2):149-56. PubMed ID: 7216371
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and norepinephrine release: interaction and effects on the heart.
Schlaich MP; Kaye DM; Lambert E; Hastings J; Campbell DJ; Lambert G; Esler MD
J Hypertens; 2005 May; 23(5):1077-82. PubMed ID: 15834295
[TBL] [Abstract][Full Text] [Related]
8. Cardiac sympathetic nerve function in congestive heart failure.
Eisenhofer G; Friberg P; Rundqvist B; Quyyumi AA; Lambert G; Kaye DM; Kopin IJ; Goldstein DS; Esler MD
Circulation; 1996 May; 93(9):1667-76. PubMed ID: 8653872
[TBL] [Abstract][Full Text] [Related]
9. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension.
Kimura S; Miura Y; Adachi M; Adachi M; Nezu M; Toriyabe S; Sugawara T; Ishizuka Y; Noshiro T; Takahashi M
Jpn Circ J; 1983 Oct; 47(10):1232-41. PubMed ID: 6632176
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic and tracer methods to study sympathetic function in primary hypertension.
Goldstein DS; Eisenhofer G; Garty M; Sax FL; Keiser HR; Kopin IJ
Clin Exp Hypertens A; 1989; 11 Suppl 1():173-89. PubMed ID: 2743589
[TBL] [Abstract][Full Text] [Related]
11. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations.
Manger WM; Frohlich ED; Gifford RW; Dustan HP
J Clin Pharmacol; 1976; 16(2-3):129-41. PubMed ID: 943425
[TBL] [Abstract][Full Text] [Related]
13. Elevated total body noradrenaline spillover in normotensive members of hypertensive families.
Ferrier C; Cox H; Esler M
Clin Sci (Lond); 1993 Feb; 84(2):225-30. PubMed ID: 8382587
[TBL] [Abstract][Full Text] [Related]
14. Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.
Esler M; Jackman G; Leonard P; Bobik A; Skews H; Jennings G; Kelleher D; Korner P
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():311s-313s. PubMed ID: 7449275
[TBL] [Abstract][Full Text] [Related]
15. Heart rate as marker of sympathetic activity.
Grassi G; Vailati S; Bertinieri G; Seravalle G; Stella ML; Dell'Oro R; Mancia G
J Hypertens; 1998 Nov; 16(11):1635-9. PubMed ID: 9856364
[TBL] [Abstract][Full Text] [Related]
16. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.
Lembo G; Napoli R; Capaldo B; Rendina V; Iaccarino G; Volpe M; Trimarco B; Saccà L
J Clin Invest; 1992 Jul; 90(1):24-9. PubMed ID: 1634611
[TBL] [Abstract][Full Text] [Related]
17. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
[TBL] [Abstract][Full Text] [Related]
18. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.
Eisenhofer G; Smolich JJ; Cox HS; Esler MD
Circulation; 1991 Sep; 84(3):1354-63. PubMed ID: 1884458
[TBL] [Abstract][Full Text] [Related]
19. Adrenal medullary overactivity in lean, borderline hypertensive young men.
Reims HM; Fossum E; Høieggen A; Moan A; Eide I; Kjeldsen SE
Am J Hypertens; 2004 Jul; 17(7):611-8. PubMed ID: 15233980
[TBL] [Abstract][Full Text] [Related]
20. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
Rundqvist B; Elam M; Bergmann-Sverrisdottir Y; Eisenhofer G; Friberg P
Circulation; 1997 Jan; 95(1):169-75. PubMed ID: 8994433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
